Snoring occurs when the vibrations of the pharyngeal airway create a respiratory sound during sleep. Snoring is associated with several disorders such a sleep apnea and hypopnea however does not indicate the presence of more serious sleep disorders. As per the ClinMed International Journal, the prevalence of snoring is estimated around 25-40% of the overall population. Treatment options like Continuous Positive Airway Pressure (CPAP) machines prove beneficial for treatment of snoring but compliance is very low owing to discomfort of wearing the device and noise it generates. Patients have shown huge interest towards intraoral device by more than three times as compared to CPAP machine to manage their snoring.

Market Insider

The Role of Regulators

A new anti-snoring and sleep apnea device known as “SnooZeal” received approval for the sale of product as over-the-counter (OTC) only in Europe in November 2016. It is represented as the first OTC product that targets the root cause of snoring and sleep apnea. The device has gained a CE marking that makes it readily available device in treating snoring and sleep apnea. The CE marking will enable SnooZeal in several major European markets that include Ireland, Germany, Spain, France, and UK.  The real novelty of the device is that it is designed as a day time treatment to address the problems associated with snoring and sleep apnea. Because of the OTC status, SnooZeal has gained immense popularity in European markets. Ease of accessibility has enabled company to build a competitive advantage with relation to its early market entrant for specific product launching.

On the other hand, the product is awaited for its approval from Food & Drug Administration (FDA) for its sales in United States that has enabled a lot of importance and garnered significant attention for its leading investors.

COVID-19 Impact and Growth Opportunities for Anti-snoring device market

In March, when the lockdown was announced the sale of anti-snoring device dropped gradually by almost 50% as supply chain was disrupted. From May, as the lockdown was lifted eventually the demand for anti-snoring device witness a rising peak as manufacturers started to sale their products through online platforms. The sale of anti-snoring devices was increased by 50% in the pandemic when compared with only 7-10% in the pre-covid. It is witnessed that there is a rising influence for online purchase of anti-snoring device rather than visiting stores personally for avoiding the severity of infection in pandemic. Therefore, this factor has gained a lot of attention for the rise of sales in anti-snoring devices in the worldwide market.   

Segmental Analysis

Anti-snoring device market is segmented by device type and surgical procedure. By device type, the market is segmented as mandibular advancement devices (MAD), tongue stabilizing devices (TSD), continuous positive airway pressure (CPAP) devices, and others. By surgical procedures, the market is segregated as somnoplasty, pillar procedure, tonsillectomy, uvulopalatopharyngoplasty (UPPP), radiofrequency and other surgical procedure.

By device type, continuous positive airway pressure (CPAP) devices segment is anticipated to hold largest market share for anti-snoring device market. Under device segment CPAP is expected to hold a CAGR of 10.48% in the forecast period. CPAP devices are utilized in cases of air blockages. The device helps to open up the airways by pushing air into them. The device comprises of a pump that controls the air pressure in the system and a tube carrying air towards the mask attached to nose and mouth. Moreover, helps in easing the functioning of airway and assist person to get sound sleep by raising the demand among the population. Therefore, CPAP devices will gain enormous attention in the coming years.      

Regional Landscape

Based on regions, the market for diabetes care devices covers North America, Asia Pacific, the Middle East & Africa, Latin America, and Europe.

Based on regions, North America will dominate the anti-snoring device market in the forecast period. It is anticipated that North America will grow at a significant CAGR of 10.2% in the coming years. The main factors that drive regional growth involve growing geriatric population coupled with obesity, high awareness regarding ill effects of snoring and related benefits, technological advancements, and rising consumption of cigarettes and alcohol.

In addition, prevalence of disorders and diseases related to healthcare raises the demand for better healthcare facilities allied with technological advancements and treatment methods. The rising need for highly trained medical professionals thus creates tremendous job opportunities in this regional market.  

Besides United States, Canada is also contributing for growth of anti-snoring market. Weight gain is a significant contributor to the snoring habits.

As per the National Sleep Foundation in 2017, snoring affected 90 million people in the US out of which 37 million people experience frequent snoring.   

Europe held the second largest share for anti-snoring device market. Factors that contribute involves presence of key manufacturers in this region, surge in awareness regarding detrimental effects associated with this condition, and untapped population suffering from this disorder. In 2019, UK accounted for major market for European markets. Technologically advanced new devices and therapeutics accelerate the growth for anti-snoring device market in Europe.

In March 2020, UK doctors a sleep disorder expert announced invention of a device that prevents people from snoring. The device is inserted into user’s mouth and flexible enough to sit in base of a mouth. The device needs to stay there for a total of 6 weeks while the person is not sleeping. Moreover, the app records users sleep patterns and provide guidance for improvement.

India anti-snoring device market will witness stupendous growth over the forthcoming years. Growing awareness regarding sleep apnea, surge in development of healthcare infrastructure, high spending capacity for the treatment costs will influence the Indian regional market for anti-snoring device.   

Competitive Landscape

Key companies profiled in this report involve Apnea Sciences Corporation (U.S.), Tomed Dr. Toussaint GmbH (Germany), Sleep Well Enjoy Life, Ltd. (U.K.), Sleeping Well, LLC (U.S.), Fisher & Paykel Healthcare Limited, Koninklijke Philips NV, and others.

Market Segmentation

Market By Device Type

Mandibular Advancement Devices (MADs)

Tongue Stabilizing Devices (TSDs)

Continuous Positive Airway Pressure (CPAP) Devices

Others

Market By Surgical Procedure

Somnoplasty

Pillar Procedure

Tonsillectomy

Uvulopalatopharyngoplasty (UPPP)

Radiofrequency

Other Surgical Procedures

Market By Geography

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa